232 related articles for article (PubMed ID: 20553278)
1. Apixaban in acute coronary syndromes.
Karthikeyan G; Eikelboom JW
Cardiovasc Ther; 2011 Oct; 29(5):285-90. PubMed ID: 20553278
[TBL] [Abstract][Full Text] [Related]
2. Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.
; Alexander JH; Becker RC; Bhatt DL; Cools F; Crea F; Dellborg M; Fox KA; Goodman SG; Harrington RA; Huber K; Husted S; Lewis BS; Lopez-Sendon J; Mohan P; Montalescot G; Ruda M; Ruzyllo W; Verheugt F; Wallentin L
Circulation; 2009 Jun; 119(22):2877-85. PubMed ID: 19470889
[TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of apixaban : where do we stand in 2013?
de Souza Brito F; Lopes RD; Alexander JH
Expert Opin Drug Saf; 2013 Jul; 12(4):559-67. PubMed ID: 23662974
[TBL] [Abstract][Full Text] [Related]
4. Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome.
Becker RC; Alexander JH; Newby LK; Yang H; Barrett Y; Mohan P; Wang J; Harrington RA; Wallentin LC
Thromb Haemost; 2010 Nov; 104(5):976-83. PubMed ID: 20806117
[TBL] [Abstract][Full Text] [Related]
5. Novel oral anticoagulants in acute coronary syndrome.
Costopoulos C; Niespialowska-Steuden M; Kukreja N; Gorog DA
Int J Cardiol; 2013 Sep; 167(6):2449-55. PubMed ID: 22989603
[TBL] [Abstract][Full Text] [Related]
6. Apixaban: an oral direct factor-xa inhibitor.
Jiménez D; Yusen RD; Ramacciotti E
Adv Ther; 2012 Mar; 29(3):187-201. PubMed ID: 22354465
[TBL] [Abstract][Full Text] [Related]
7. The role of apixaban for venous and arterial thromboembolic disease.
Prom R; Spinler SA
Ann Pharmacother; 2011 Oct; 45(10):1262-83. PubMed ID: 21954450
[TBL] [Abstract][Full Text] [Related]
8. Apixaban for the prevention of stroke in atrial fibrillation.
Littrell R; Flaker G
Expert Rev Cardiovasc Ther; 2012 Feb; 10(2):143-9. PubMed ID: 22292869
[TBL] [Abstract][Full Text] [Related]
9. Apixaban in other situations?
Prescrire Int; 2012 Sep; 21(130):203. PubMed ID: 23016248
[No Abstract] [Full Text] [Related]
10. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.
Lassen MR; Gallus A; Raskob GE; Pineo G; Chen D; Ramirez LM;
N Engl J Med; 2010 Dec; 363(26):2487-98. PubMed ID: 21175312
[TBL] [Abstract][Full Text] [Related]
11. Apixaban, an oral, direct inhibitor of activated Factor Xa.
Shantsila E; Lip GY
Curr Opin Investig Drugs; 2008 Sep; 9(9):1020-33. PubMed ID: 18729009
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of stroke in nonvalvular atrial fibrillation. Oral direct factor Xa inhibitor apixaban: positive experiences in general medical practice].
MMW Fortschr Med; 2013 Sep; 155(16):62-3. PubMed ID: 24279159
[No Abstract] [Full Text] [Related]
13. A new generation of oral direct anticoagulants.
Soff GA
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):569-74. PubMed ID: 22345595
[TBL] [Abstract][Full Text] [Related]
14. Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
Lopes RD; Alexander JH; Al-Khatib SM; Ansell J; Diaz R; Easton JD; Gersh BJ; Granger CB; Hanna M; Horowitz J; Hylek EM; McMurray JJ; Verheugt FW; Wallentin L;
Am Heart J; 2010 Mar; 159(3):331-9. PubMed ID: 20211292
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulants for the treatment of acute coronary syndrome in the era of new oral agents.
Kar S; Bhatt DL
Coron Artery Dis; 2012 Sep; 23(6):380-90. PubMed ID: 22728913
[TBL] [Abstract][Full Text] [Related]
16. Is Apixaban (Eliquis) the "ideal" anticoagulant to replace warfarin for stroke prevention in atrial fibrillation?
Strain J; Templeton K
S D Med; 2013 Jan; 66(1):20-1. PubMed ID: 23342716
[No Abstract] [Full Text] [Related]
17. Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban.
Morell J; Sullivan B; Khalabuda M; McBride BF
J Clin Pharmacol; 2010 Sep; 50(9):986-1000. PubMed ID: 20124518
[TBL] [Abstract][Full Text] [Related]
18. Oral apixaban for the treatment of acute venous thromboembolism.
Agnelli G; Buller HR; Cohen A; Curto M; Gallus AS; Johnson M; Masiukiewicz U; Pak R; Thompson J; Raskob GE; Weitz JI;
N Engl J Med; 2013 Aug; 369(9):799-808. PubMed ID: 23808982
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgery.
Martin MT; Nutescu EA
Curr Med Res Opin; 2011 Nov; 27(11):2123-31. PubMed ID: 21942466
[TBL] [Abstract][Full Text] [Related]
20. Apixaban versus enoxaparin in patients with total knee arthroplasty. A meta-analysis of randomised trials.
Huang J; Cao Y; Liao C; Wu L; Gao F
Thromb Haemost; 2011 Feb; 105(2):245-53. PubMed ID: 20941455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]